| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > 3 Things I Love About Email Marketing |
|
Digg It - 3 Things I Love About Email Marketing
Email Marketing Rocks - 3 Things I love about Email Marketing The first thing t According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product hat I love about Email Marketing is its Speed. Email is instantaneous. The moment I send out a newsletter ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in or promotional offer to my subscribers, I get to see the results. People start to open, read and respond t lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. o the email almost immediately. I used to wait for many days or weeks before I would see any response to here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe my print promotions. The second thing that I love about Email Marketing is its reach. I have so many CEO, d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro COO, business owners and senior executives on the list, and I have the power to reach them almost immedia ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc tely, with every email newsletter I send out. Previously, with print media, I could only hope that the se easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi cretary that opens the mail would keep the offer letter for the CEO to see. Now I have the confidence that nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically my offer will be seen by the decision maker's eyes only. Most senior executives still see their own email and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ , and very few get a secretary to filter email. Long live the Blackberry! The third thing that I love abo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ut Email Marketing is that I can test what works and what does not. For example, I can test two different ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a subject lines, and see which one gets a higher open rate, a higher click through rate. Normally I send ou dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t a test newsletter to about 500 people, each with a different subject line. The one that gets opened more cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin , is selected, and sent to the remaining list. This kind of testing gives us a winner, which results in a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen higher response rate from the entire list. I couldn't imagine to do this with print media. The amount of t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel time required for testing, evaluating, gathering the response is enormous. On top of this, the cost of pri ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nting different brochures is simply not practical. Summary: There you go. These are the top 3 reasons I y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products love Email Marketing hands down! You too can win with Email Marketing, whether you do B2B or B2C campaign . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de s. Simply start using email to connect with your clients and prospects, and you will see an improvement in elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip your business, your bottom line, and your confidence! Just remember not to spam anyone. To your success, tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Which Comes First, Branding or Marketing? Effective Presentation Skills - Eliminate Pause Fillers What to Do With Your Hands - Two Tips for Feeling Comfortable at Events
|